<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>Cure Parkinsons - Past Research Events</title><link>http://www.cureparkinsons.org.uk</link><description>Latest content from parkinsons.</description><language>en-gb</language><item><title>Parkinson's and Genetics Conference</title><link>http://www.cureparkinsons.org.uk/redirect.aspx?module=3&amp;doc=0:43195&amp;tid=rss</link><guid>http://www.cureparkinsons.org.uk/redirect.aspx?module=3&amp;doc=0:43195&amp;tid=rss</guid><pubDate>Tue, 05 Jan 2010 16:56:11 GMT</pubDate><description>
		
				
				On the 1st December 2009 at the Royal Society of Medicine we hosted a conference to examine the recent research regarding the importance of genetics as a cause of Parkinson's disease. Leading international specialists in genetics attended the conference and the speakers were experts from the UK, Europe and the USA.
		
		
				
						Click here for a full report of the conference.
		
		
				
				 
</description></item><item><title>Scientific Conference on Calcium and Parkinson's.</title><link>http://www.cureparkinsons.org.uk/redirect.aspx?module=3&amp;doc=0:43013&amp;tid=rss</link><guid>http://www.cureparkinsons.org.uk/redirect.aspx?module=3&amp;doc=0:43013&amp;tid=rss</guid><pubDate>Thu, 26 Nov 2009 16:47:37 GMT</pubDate><description>
		On the 3rd November 2009 at the Royal Society of Medicine, we hosted the first ever conference on the role of calcium (and Vitamin D) in PD. Leading experts from the UK, USA and Switzerland who specialise in various aspects of research into the relevance of calcium to the prevention and treatment of PD gave presentations describing their current research, including on-going calcium-related clinical trials in PD.  
		
				Click here for a report of the conference
		
				Click here for further details on the role of Vitamin D and Calcium in Parkinson's.
		 
</description></item><item><title>Medicine and Me, Newcastle, November 10th 2009</title><link>http://www.cureparkinsons.org.uk/redirect.aspx?module=3&amp;doc=0:42938&amp;tid=rss</link><guid>http://www.cureparkinsons.org.uk/redirect.aspx?module=3&amp;doc=0:42938&amp;tid=rss</guid><pubDate>Fri, 13 Nov 2009 10:16:45 GMT</pubDate><description>
		Following on from our successful 2008 Medicine and Me meeting, we co-hosted a patient meeting in Newcastle ( at the Newcastle General Hospital) with the Royal Society of Medicine (RSM) and Newcastle University. The meeting was hosted by Professor David Burn, chair of the movement disorders &amp; neurology department at Newcastle University and chaired by Dr John Scadding, Emeritus Dean, RSM.
		
				Click here to read a summary of the key issues discussed
		 
</description></item><item><title>Patient Meeting Rugby, 3rd September 2009</title><link>http://www.cureparkinsons.org.uk/redirect.aspx?module=3&amp;doc=0:42478&amp;tid=rss</link><guid>http://www.cureparkinsons.org.uk/redirect.aspx?module=3&amp;doc=0:42478&amp;tid=rss</guid><pubDate>Mon, 14 Sep 2009 15:09:17 GMT</pubDate><description>
		
				Our patient meeting held at Rugby School proved to be an informative and lively discussion arena. If you were unable to attend the day and would like to find out about the key points discussed please click here for a summary of the meeting.  Click here to download Dr Jon Stamford's presentation looking at the future of Parkinson's treatments,  and in addition, you  can read Tom Isaacs' speech by clicking here. If you were not able to attend our Rugby meeting, we have another meeting planned for the 10th November in Newcastle, Click here for further details. 
</description></item><item><title>Forum on the role of anti - inflamatories in Pa...</title><link>http://www.cureparkinsons.org.uk/redirect.aspx?module=3&amp;doc=0:39101&amp;tid=rss</link><guid>http://www.cureparkinsons.org.uk/redirect.aspx?module=3&amp;doc=0:39101&amp;tid=rss</guid><pubDate>Mon, 04 Aug 2008 16:13:07 GMT</pubDate><description>
		
				
						Royal Society of Medicine, London 
				
						 10th - 11th November 2008
				
		
		
				This November, The Cure Parkinsons Trust hosted a two day conference at the Royal Society of Medicine in London where leading scientists and clinicians from around the world discussed the potential of using anti-inflammatory and anti-oxidative therapies to treat Parkinson’s Disease, and most especially, to slow its progression. 
				The past 2-3 years have seen enormous interest in this promising field of research, and several different drug and lifestyle nutritional approaches have emerged from it which offer both theoretical and tangible, now proven, benefits.   There is ample evidence that an inflammatory response occurs in brain cells in Parkinson’s Disease. Some scientists say it is a fundamental part of the disease process, others feel it is just a response to it. Whatever the truth, many agree that this inflammation increases local damage to brain cells, and therefore accelerates disease progression.  Accordingly, many are...</description></item><item><title>Medicine and Me:  Parkinson's Disease</title><link>http://www.cureparkinsons.org.uk/redirect.aspx?module=3&amp;doc=0:38055&amp;tid=rss</link><guid>http://www.cureparkinsons.org.uk/redirect.aspx?module=3&amp;doc=0:38055&amp;tid=rss</guid><pubDate>Mon, 04 Aug 2008 16:15:47 GMT</pubDate><description>
		
		
		
				
						
								
										
												
												
												
										
								
						
				
		
		
				
						
				
		
		
				Medicine and Me conferences, initiated and developed by the Royal Society of Medicine, are specifically designed for patients.  These meetings bring together patients, their families, carers, advocates, patient support groups, clinicians and researchers to discuss care and research issues into a particular condition.
				Medicine and Me: Parkinson’s disease was jointly organised by the Royal Society of Medicine and The Cure Parkinson’s Trust.
		
		
				Medicine and Me meetings aim to provide a forum in which patient’s concerns about their illness are given top priority.  The meetings provide an opportunity for patients and their families to share their experiences, to hear about the latest research and to question the experts.
				The audience at the meeting comprised of those with Parkinson’s disease, their families, carers and advocates representing about 70% of those present and clinicians and researchers representing not more than 30%.  Clinicians  includes doctors, specialist nurses and others involved in the treatment and care of those with...</description></item></channel></rss>